News Author: Sara Freeman Publish date: June 25, 2016
LONDON – Patients with psoriatic arthritis appear less likely to achieve a good response to their first anti-tumor necrosis factor therapy if they are...
News Author: Sara Freeman Publish date: June 25, 2016
Key clinical point: Obesity may reduce response and adherence to tumor necrosis factor–inhibitor therapy in patients with psoriatic arthriti...
News Author: Sara Freeman Publish date: June 25, 2016
News Author: Sara Freeman Publish date: June 23, 2016
Key clinical point: Early clinical data show that a novel injectable drug holds promise for becoming the first disease-modifying osteoarthritis dr...
News Author: Sara Freeman Publish date: June 19, 2016
News Author: Sara Freeman Publish date: June 15, 2016
Video Author: Sara Freeman Publish date: June 15, 2016
News Author: Sara Freeman Publish date: June 14, 2016
News Author: Sara Freeman Publish date: June 14, 2016
News Author: Sara Freeman Publish date: June 12, 2016
Prompt referral to a rheumatologist and early initiation of treatment remain 2 of the 12 key recommendations in the updated European League Against Rh...
News Author: Sara Freeman Publish date: June 10, 2016
Key clinical point: The survival of patients with giant cell arteritis has more than doubled in the past 20 years.
Major finding: Comparing two co...
News Author: Sara Freeman Publish date: June 9, 2016
LONDON – Targeting tumor necrosis factor could benefit patients with erosive hand disease.
News Author: Sara Freeman Publish date: June 9, 2016
Key clinical point: Women with SLE should be encouraged to be screened for cervical cancer, particularly those treated with immunosuppressive drug...
News Author: Sara Freeman Publish date: May 10, 2016
Key clinical point: There is a low risk of vasculitis-like events with tumor necrosis factor inhibitors.
Major finding: Crude incidence rates for ...
News Author: Sara Freeman Publish date: May 10, 2016
Key clinical point: Patients with vascular disease who develop giant cell arteritis may require careful monitoring for sight loss.
Major finding: ...
